UBP10_HUMAN - dbPTM
UBP10_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UBP10_HUMAN
UniProt AC Q14694
Protein Name Ubiquitin carboxyl-terminal hydrolase 10
Gene Name USP10
Organism Homo sapiens (Human).
Sequence Length 798
Subcellular Localization Cytoplasm . Nucleus . Early endosome . Cytoplasmic in normal conditions (PubMed:20096447). After DNA damage, translocates to the nucleus following phosphorylation by ATM (PubMed:20096447).
Protein Description Hydrolase that can remove conjugated ubiquitin from target proteins such as p53/TP53, BECN1, SNX3 and CFTR. Acts as an essential regulator of p53/TP53 stability: in unstressed cells, specifically deubiquitinates p53/TP53 in the cytoplasm, leading to counteract MDM2 action and stabilize p53/TP53. Following DNA damage, translocates to the nucleus and deubiquitinates p53/TP53, leading to regulate the p53/TP53-dependent DNA damage response. Component of a regulatory loop that controls autophagy and p53/TP53 levels: mediates deubiquitination of BECN1, a key regulator of autophagy, leading to stabilize the PIK3C3/VPS34-containing complexes. In turn, PIK3C3/VPS34-containing complexes regulate USP10 stability, suggesting the existence of a regulatory system by which PIK3C3/VPS34-containing complexes regulate p53/TP53 protein levels via USP10 and USP13. Does not deubiquitinate MDM2. Deubiquitinates CFTR in early endosomes, enhancing its endocytic recycling. Involved in a TANK-dependent negative feedback response to attenuate NF-kappaB activation via deubiquitinating IKBKG or TRAF6 in response to interleukin-1-beta (IL1B) stimulation or upon DNA damage. [PubMed: 25861989 Deubiquitinates TBX21 leading to its stabilization]
Protein Sequence MALHSPQYIFGDFSPDEFNQFFVTPRSSVELPPYSGTVLCGTQAVDKLPDGQEYQRIEFGVDEVIEPSDTLPRTPSYSISSTLNPQAPEFILGCTASKITPDGITKEASYGSIDCQYPGSALALDGSSNVEAEVLENDGVSGGLGQRERKKKKKRPPGYYSYLKDGGDDSISTEALVNGHANSAVPNSVSAEDAEFMGDMPPSVTPRTCNSPQNSTDSVSDIVPDSPFPGALGSDTRTAGQPEGGPGADFGQSCFPAEAGRDTLSRTAGAQPCVGTDTTENLGVANGQILESSGEGTATNGVELHTTESIDLDPTKPESASPPADGTGSASGTLPVSQPKSWASLFHDSKPSSSSPVAYVETKYSPPAISPLVSEKQVEVKEGLVPVSEDPVAIKIAELLENVTLIHKPVSLQPRGLINKGNWCYINATLQALVACPPMYHLMKFIPLYSKVQRPCTSTPMIDSFVRLMNEFTNMPVPPKPRQALGDKIVRDIRPGAAFEPTYIYRLLTVNKSSLSEKGRQEDAEEYLGFILNGLHEEMLNLKKLLSPSNEKLTISNGPKNHSVNEEEQEEQGEGSEDEWEQVGPRNKTSVTRQADFVQTPITGIFGGHIRSVVYQQSSKESATLQPFFTLQLDIQSDKIRTVQDALESLVARESVQGYTTKTKQEVEISRRVTLEKLPPVLVLHLKRFVYEKTGGCQKLIKNIEYPVDLEISKELLSPGVKNKNFKCHRTYRLFAVVYHHGNSATGGHYTTDVFQIGLNGWLRIDDQTVKVINQYQVVKPTAERTAYLLYYRRVDLL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MALHSPQYI
------CCCCCCCEE
17.6220068231
5Phosphorylation---MALHSPQYIFGD
---CCCCCCCEECCC
17.9725159151
8PhosphorylationMALHSPQYIFGDFSP
CCCCCCCEECCCCCH
11.1228450419
14PhosphorylationQYIFGDFSPDEFNQF
CEECCCCCHHHHHCC
35.8628464451
24PhosphorylationEFNQFFVTPRSSVEL
HHHCCEECCCCCCCC
14.0820068231
27PhosphorylationQFFVTPRSSVELPPY
CCEECCCCCCCCCCC
39.6825159151
28PhosphorylationFFVTPRSSVELPPYS
CEECCCCCCCCCCCC
22.3825159151
32PhosphorylationPRSSVELPPYSGTVL
CCCCCCCCCCCCEEE
16.5727251275
34PhosphorylationSSVELPPYSGTVLCG
CCCCCCCCCCEEEEC
20.1427251275
35PhosphorylationSVELPPYSGTVLCGT
CCCCCCCCCEEEECC
33.4927251275
37PhosphorylationELPPYSGTVLCGTQA
CCCCCCCEEEECCEE
12.3627251275
42PhosphorylationSGTVLCGTQAVDKLP
CCEEEECCEEEECCC
16.6228796482
47AcetylationCGTQAVDKLPDGQEY
ECCEEEECCCCCCEE
56.1526051181
54PhosphorylationKLPDGQEYQRIEFGV
CCCCCCEEEEEECCC
8.6628796482
68PhosphorylationVDEVIEPSDTLPRTP
CCCEECCCCCCCCCC
30.3628387310
70PhosphorylationEVIEPSDTLPRTPSY
CEECCCCCCCCCCCC
42.8926074081
74PhosphorylationPSDTLPRTPSYSISS
CCCCCCCCCCCCCCC
18.0423401153
76PhosphorylationDTLPRTPSYSISSTL
CCCCCCCCCCCCCCC
30.7921945579
77PhosphorylationTLPRTPSYSISSTLN
CCCCCCCCCCCCCCC
15.9521945579
78PhosphorylationLPRTPSYSISSTLNP
CCCCCCCCCCCCCCC
21.9721945579
80PhosphorylationRTPSYSISSTLNPQA
CCCCCCCCCCCCCCC
16.0121945579
81PhosphorylationTPSYSISSTLNPQAP
CCCCCCCCCCCCCCC
34.9321945579
82PhosphorylationPSYSISSTLNPQAPE
CCCCCCCCCCCCCCC
24.6221945579
94GlutathionylationAPEFILGCTASKITP
CCCEEEEEECCCCCC
2.2922555962
95PhosphorylationPEFILGCTASKITPD
CCEEEEEECCCCCCC
31.9721945579
97PhosphorylationFILGCTASKITPDGI
EEEEEECCCCCCCCC
13.3621945579
100PhosphorylationGCTASKITPDGITKE
EEECCCCCCCCCCCE
21.0430266825
104PhosphorylationSKITPDGITKEASYG
CCCCCCCCCCEECCC
6.9227251275
105PhosphorylationKITPDGITKEASYGS
CCCCCCCCCEECCCC
28.5024732914
109PhosphorylationDGITKEASYGSIDCQ
CCCCCEECCCCCCCC
30.9928348404
110PhosphorylationGITKEASYGSIDCQY
CCCCEECCCCCCCCC
23.1828102081
112PhosphorylationTKEASYGSIDCQYPG
CCEECCCCCCCCCCC
13.6628348404
116PhosphorylationSYGSIDCQYPGSALA
CCCCCCCCCCCCEEE
43.6527251275
117PhosphorylationYGSIDCQYPGSALAL
CCCCCCCCCCCEEEE
18.8528102081
120PhosphorylationIDCQYPGSALALDGS
CCCCCCCCEEEECCC
18.6628102081
127PhosphorylationSALALDGSSNVEAEV
CEEEECCCCCEEEEE
20.5728348404
128PhosphorylationALALDGSSNVEAEVL
EEEECCCCCEEEEEH
50.8828348404
154UbiquitinationRERKKKKKRPPGYYS
HHHHCCCCCCCCHHH
78.13-
159PhosphorylationKKKRPPGYYSYLKDG
CCCCCCCHHHHCCCC
8.6021945579
160PhosphorylationKKRPPGYYSYLKDGG
CCCCCCHHHHCCCCC
9.2121945579
161PhosphorylationKRPPGYYSYLKDGGD
CCCCCHHHHCCCCCC
18.5921945579
162PhosphorylationRPPGYYSYLKDGGDD
CCCCHHHHCCCCCCC
11.1421945579
203PhosphorylationFMGDMPPSVTPRTCN
HHCCCCCCCCCCCCC
32.5226471730
205PhosphorylationGDMPPSVTPRTCNSP
CCCCCCCCCCCCCCC
16.0518669648
208PhosphorylationPPSVTPRTCNSPQNS
CCCCCCCCCCCCCCC
19.7629255136
209PhosphorylationPSVTPRTCNSPQNST
CCCCCCCCCCCCCCC
5.1127251275
211PhosphorylationVTPRTCNSPQNSTDS
CCCCCCCCCCCCCCC
29.9729255136
215PhosphorylationTCNSPQNSTDSVSDI
CCCCCCCCCCCHHHC
28.4829255136
216PhosphorylationCNSPQNSTDSVSDIV
CCCCCCCCCCHHHCC
39.5823927012
218PhosphorylationSPQNSTDSVSDIVPD
CCCCCCCCHHHCCCC
24.4930278072
220PhosphorylationQNSTDSVSDIVPDSP
CCCCCCHHHCCCCCC
26.1020201521
222PhosphorylationSTDSVSDIVPDSPFP
CCCCHHHCCCCCCCC
3.6427251275
224PhosphorylationDSVSDIVPDSPFPGA
CCHHHCCCCCCCCCC
36.3727251275
226PhosphorylationVSDIVPDSPFPGALG
HHHCCCCCCCCCCCC
23.5223927012
230PhosphorylationVPDSPFPGALGSDTR
CCCCCCCCCCCCCCC
33.5427251275
234PhosphorylationPFPGALGSDTRTAGQ
CCCCCCCCCCCCCCC
36.3420068231
236PhosphorylationPGALGSDTRTAGQPE
CCCCCCCCCCCCCCC
31.4520068231
253PhosphorylationPGADFGQSCFPAEAG
CCCCCCCCCCCHHCC
20.3626552605
254GlutathionylationGADFGQSCFPAEAGR
CCCCCCCCCCHHCCC
3.4922555962
263PhosphorylationPAEAGRDTLSRTAGA
CHHCCCCCHHCCCCC
25.8526552605
265PhosphorylationEAGRDTLSRTAGAQP
HCCCCCHHCCCCCCC
29.6726552605
309PhosphorylationVELHTTESIDLDPTK
EEEEECCEECCCCCC
21.2222468782
315PhosphorylationESIDLDPTKPESASP
CEECCCCCCCCCCCC
59.9226074081
319PhosphorylationLDPTKPESASPPADG
CCCCCCCCCCCCCCC
42.4426074081
321PhosphorylationPTKPESASPPADGTG
CCCCCCCCCCCCCCC
40.4727050516
327PhosphorylationASPPADGTGSASGTL
CCCCCCCCCCCCCCE
28.6326074081
329PhosphorylationPPADGTGSASGTLPV
CCCCCCCCCCCCEEC
21.0626074081
331PhosphorylationADGTGSASGTLPVSQ
CCCCCCCCCCEECCC
33.7326074081
333PhosphorylationGTGSASGTLPVSQPK
CCCCCCCCEECCCCC
25.9526074081
337PhosphorylationASGTLPVSQPKSWAS
CCCCEECCCCCCHHH
38.5326074081
341PhosphorylationLPVSQPKSWASLFHD
EECCCCCCHHHHCCC
34.2625159151
344PhosphorylationSQPKSWASLFHDSKP
CCCCCHHHHCCCCCC
25.8828464451
349PhosphorylationWASLFHDSKPSSSSP
HHHHCCCCCCCCCCC
37.5926074081
350AcetylationASLFHDSKPSSSSPV
HHHCCCCCCCCCCCE
55.7825953088
352PhosphorylationLFHDSKPSSSSPVAY
HCCCCCCCCCCCEEE
46.7320068231
353PhosphorylationFHDSKPSSSSPVAYV
CCCCCCCCCCCEEEE
43.2825159151
354PhosphorylationHDSKPSSSSPVAYVE
CCCCCCCCCCEEEEE
42.8925159151
355PhosphorylationDSKPSSSSPVAYVET
CCCCCCCCCEEEEEE
25.9125159151
359PhosphorylationSSSSPVAYVETKYSP
CCCCCEEEEEECCCC
10.0722115753
362PhosphorylationSPVAYVETKYSPPAI
CCEEEEEECCCCCCC
25.8223898821
363AcetylationPVAYVETKYSPPAIS
CEEEEEECCCCCCCC
30.1726051181
364PhosphorylationVAYVETKYSPPAISP
EEEEEECCCCCCCCC
33.5519664994
365PhosphorylationAYVETKYSPPAISPL
EEEEECCCCCCCCCC
26.4329255136
369PhosphorylationTKYSPPAISPLVSEK
ECCCCCCCCCCCCCC
5.5627251275
370PhosphorylationKYSPPAISPLVSEKQ
CCCCCCCCCCCCCCC
17.8119664994
374PhosphorylationPAISPLVSEKQVEVK
CCCCCCCCCCCEEEE
46.9229255136
376AcetylationISPLVSEKQVEVKEG
CCCCCCCCCEEEECC
52.7325953088
376UbiquitinationISPLVSEKQVEVKEG
CCCCCCCCCEEEECC
52.73-
381UbiquitinationSEKQVEVKEGLVPVS
CCCCEEEECCCEECC
32.34-
395UbiquitinationSEDPVAIKIAELLEN
CCCHHHHHHHHHHHC
26.57-
408AcetylationENVTLIHKPVSLQPR
HCEEEECCCCCCCCC
39.8726051181
408UbiquitinationENVTLIHKPVSLQPR
HCEEEECCCCCCCCC
39.8721890473
412UbiquitinationLIHKPVSLQPRGLIN
EECCCCCCCCCCCCC
9.1721890473
456 (in isoform 2)Ubiquitination-5.24-
488AcetylationPRQALGDKIVRDIRP
CCCCCCCHHHHCCCC
41.1025953088
488UbiquitinationPRQALGDKIVRDIRP
CCCCCCCHHHHCCCC
41.10-
503PhosphorylationGAAFEPTYIYRLLTV
CCCCCCEEEEEEEEE
13.48-
512UbiquitinationYRLLTVNKSSLSEKG
EEEEEECHHHCCHHC
36.77-
513PhosphorylationRLLTVNKSSLSEKGR
EEEEECHHHCCHHCC
31.1629978859
514PhosphorylationLLTVNKSSLSEKGRQ
EEEECHHHCCHHCCH
37.2129978859
516PhosphorylationTVNKSSLSEKGRQED
EECHHHCCHHCCHHH
38.9329978859
518AcetylationNKSSLSEKGRQEDAE
CHHHCCHHCCHHHHH
56.8925953088
518UbiquitinationNKSSLSEKGRQEDAE
CHHHCCHHCCHHHHH
56.89-
527PhosphorylationRQEDAEEYLGFILNG
CHHHHHHHHHHHHHH
12.02-
536 (in isoform 2)Ubiquitination-30.30-
544UbiquitinationEEMLNLKKLLSPSNE
HHHHCHHHHHCCCCC
58.80-
547PhosphorylationLNLKKLLSPSNEKLT
HCHHHHHCCCCCCCE
36.4029255136
549PhosphorylationLKKLLSPSNEKLTIS
HHHHHCCCCCCCEEC
55.0023401153
551PhosphorylationKLLSPSNEKLTISNG
HHHCCCCCCCEECCC
54.5027251275
552UbiquitinationLLSPSNEKLTISNGP
HHCCCCCCCEECCCC
56.00-
554PhosphorylationSPSNEKLTISNGPKN
CCCCCCCEECCCCCC
33.1726074081
556PhosphorylationSNEKLTISNGPKNHS
CCCCCEECCCCCCCC
30.4225159151
563PhosphorylationSNGPKNHSVNEEEQE
CCCCCCCCCCHHHHH
35.7123927012
576PhosphorylationQEEQGEGSEDEWEQV
HHHCCCCCHHHHHHC
37.2622167270
580PhosphorylationGEGSEDEWEQVGPRN
CCCCHHHHHHCCCCC
17.4027251275
600PhosphorylationRQADFVQTPITGIFG
HHHCCEECCCCCCCC
16.0327251275
600 (in isoform 2)Ubiquitination-16.03-
604PhosphorylationFVQTPITGIFGGHIR
CEECCCCCCCCCEEE
17.5927251275
615NitrationGHIRSVVYQQSSKES
CEEEEEEEECCCCCC
9.93-
659PhosphorylationARESVQGYTTKTKQE
HHHHHCCCCCCCCCE
8.31-
662AcetylationSVQGYTTKTKQEVEI
HHCCCCCCCCCEEEE
46.0225953088
662UbiquitinationSVQGYTTKTKQEVEI
HHCCCCCCCCCEEEE
46.02-
664UbiquitinationQGYTTKTKQEVEISR
CCCCCCCCCEEEEEE
46.12-
670PhosphorylationTKQEVEISRRVTLEK
CCCEEEEEECCCHHH
10.67-
674PhosphorylationVEISRRVTLEKLPPV
EEEEECCCHHHCCCE
27.64-
677AcetylationSRRVTLEKLPPVLVL
EECCCHHHCCCEEEE
70.2126051181
677UbiquitinationSRRVTLEKLPPVLVL
EECCCHHHCCCEEEE
70.21-
687AcetylationPVLVLHLKRFVYEKT
CEEEEEEEEHHHHHC
32.8025953088
691PhosphorylationLHLKRFVYEKTGGCQ
EEEEEHHHHHCCCHH
14.7021214269
693AcetylationLKRFVYEKTGGCQKL
EEEHHHHHCCCHHHH
34.4825953088
693MalonylationLKRFVYEKTGGCQKL
EEEHHHHHCCCHHHH
34.4826320211
693UbiquitinationLKRFVYEKTGGCQKL
EEEHHHHHCCCHHHH
34.48-
694PhosphorylationKRFVYEKTGGCQKLI
EEHHHHHCCCHHHHH
27.2021214269
699AcetylationEKTGGCQKLIKNIEY
HHCCCHHHHHHCCCC
57.1425953088
699UbiquitinationEKTGGCQKLIKNIEY
HHCCCHHHHHHCCCC
57.14-
702AcetylationGGCQKLIKNIEYPVD
CCHHHHHHCCCCCCC
63.4126051181
702UbiquitinationGGCQKLIKNIEYPVD
CCHHHHHHCCCCCCC
63.41-
710 (in isoform 2)Ubiquitination-6.83-
712 (in isoform 2)Ubiquitination-10.42-
713PhosphorylationYPVDLEISKELLSPG
CCCCHHHCHHHCCCC
15.6518669648
714AcetylationPVDLEISKELLSPGV
CCCHHHCHHHCCCCC
59.0323954790
714UbiquitinationPVDLEISKELLSPGV
CCCHHHCHHHCCCCC
59.03-
718PhosphorylationEISKELLSPGVKNKN
HHCHHHCCCCCCCCC
32.0330266825
722PhosphorylationELLSPGVKNKNFKCH
HHCCCCCCCCCCEEC
69.0327251275
722UbiquitinationELLSPGVKNKNFKCH
HHCCCCCCCCCCEEC
69.03-
725 (in isoform 2)Ubiquitination-51.51-
741 (in isoform 2)Malonylation-21.3126320211
741 (in isoform 2)Ubiquitination-21.31-
750 (in isoform 2)Ubiquitination-18.01-
762 (in isoform 2)Ubiquitination-4.96-
769PhosphorylationWLRIDDQTVKVINQY
EEEECCCEEEEEEEE
29.3228258704
771AcetylationRIDDQTVKVINQYQV
EECCCEEEEEEEEEE
40.5626051181
780AcetylationINQYQVVKPTAERTA
EEEEEEECCCHHHEE
37.4826822725
780UbiquitinationINQYQVVKPTAERTA
EEEEEEECCCHHHEE
37.482190698
786PhosphorylationVKPTAERTAYLLYYR
ECCCHHHEEEEEEEE
15.9128152594
788PhosphorylationPTAERTAYLLYYRRV
CCHHHEEEEEEEEEC
9.1628152594
791PhosphorylationERTAYLLYYRRVDLL
HHEEEEEEEEECCCC
7.7328176443
792PhosphorylationRTAYLLYYRRVDLL-
HEEEEEEEEECCCC-
7.6028176443
828 (in isoform 2)Malonylation-26320211
828 (in isoform 2)Ubiquitination--

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
42TPhosphorylationKinaseATMQ13315
Uniprot
76SPhosphorylationKinasePRKAA1Q13131
GPS
337SPhosphorylationKinaseATMQ13315
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UBP10_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UBP10_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
G3BP1_HUMANG3BP1physical
11439350
SCNNA_HUMANSCNN1Aphysical
18632802
IF4G1_HUMANEIF4G1physical
19615732
IF4G3_HUMANEIF4G3physical
19615732
G3BP2_HUMANG3BP2physical
19615732
G3BP1_HUMANG3BP1physical
19615732
CELF1_HUMANCELF1physical
19615732
GAR1_HUMANGAR1physical
19615732
P53_HUMANTP53physical
20096447
CFTR_HUMANCFTRphysical
20215869
CFTR_HUMANCFTRphysical
19398555
UBC_HUMANUBCphysical
19398555
ANDR_HUMANARphysical
16368182
WAPL_HUMANWAPALphysical
22939629
ZCH18_HUMANZC3H18physical
22939629
UBP15_HUMANUSP15physical
22939629
ZN281_HUMANZNF281physical
22939629
UBC_HUMANUBCphysical
23287719
PABP1_HUMANPABPC1physical
23230274
G3BP1_HUMANG3BP1physical
23230274
PTEN_HUMANPTENphysical
24270891
ZC12A_HUMANZC3H12Aphysical
24270572
NEMO_HUMANIKBKGphysical
24270572
UBP10_HUMANUSP10physical
24998844
P53_HUMANTP53physical
24998844
G3BP1_HUMANG3BP1physical
24998844
G3BP2_HUMANG3BP2physical
25416956
G3BP1_HUMANG3BP1physical
26344197
SF3B3_HUMANSF3B3physical
26344197
AAPK1_HUMANPRKAA1physical
26876938
AAPK2_HUMANPRKAA2physical
26876938
TANK_HUMANTANKphysical
25861989
ZC12A_HUMANZC3H12Aphysical
25861989
IF4G1_HUMANEIF4G1physical
27003362
H2A2C_HUMANHIST2H2ACphysical
21245042
MSH2_HUMANMSH2physical
26975374
ANR44_HUMANANKRD44physical
28514442
G3BP2_HUMANG3BP2physical
28514442
ANR52_HUMANANKRD52physical
28514442
AASD1_HUMANAARSD1physical
28514442
ANR28_HUMANANKRD28physical
28514442
P4R3A_HUMANSMEK1physical
28514442
GFAP_HUMANGFAPphysical
28514442
PP6R2_HUMANPPP6R2physical
28514442
KLDC3_HUMANKLHDC3physical
28514442
G3BP1_HUMANG3BP1physical
28514442
PP6R1_HUMANPPP6R1physical
28514442
PP4R2_HUMANPPP4R2physical
28514442
ZEB1_HUMANZEB1physical
29119051
PTEN_HUMANPTENphysical
28852924
RN168_HUMANRNF168physical
27558965
G3BP1_HUMANG3BP1physical
27022092
G3BP2_HUMANG3BP2physical
27022092
PABP1_HUMANPABPC1physical
27022092
RS6_HUMANRPS6physical
27022092
IF4G1_HUMANEIF4G1physical
27022092

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UBP10_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"USP10 regulates p53 localization and stability by deubiquitinatingp53.";
Yuan J., Luo K., Zhang L., Cheville J.C., Lou Z.;
Cell 140:384-396(2010).
Cited for: FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INDUCTION,INTERACTION WITH TP53, PHOSPHORYLATION AT THR-42; SER-337 AND CYS-424,AND MUTAGENESIS OF THR-42 AND SER-337.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563 AND SER-576, ANDMASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-208; SER-365; SER-370;SER-547 AND SER-576, AND MASS SPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-220; SER-226;SER-370; SER-563 AND SER-576, AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction.";
Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.;
Mol. Cell. Proteomics 6:1952-1967(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY.
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline.";
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
Electrophoresis 28:2027-2034(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-364; SER-365 ANDSER-370, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-576, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211 AND SER-576, ANDMASS SPECTROMETRY.

TOP